Hims

Hims is a direct-to-consumer telehealth and health products company that serves men seeking convenient, discreet access to treatments for conditions that are frequently undertreated in traditional healthcare settings. The platform covers a range of men's health categories: weight loss (including GLP-1 medications), erectile dysfunction, hair loss, mental health (anxiety and depression), skincare, and sexual health. Hims operates on an asynchronous telehealth model. Patients complete detailed online health intakes rather than scheduling live video appointments, and licensed clinicians review responses to determine clinical candidacy. When approved, prescriptions are written and medications ship directly from licensed pharmacy partners to the patient's home. Ongoing management — prescription renewals, dosage questions, and clinical check-ins — is handled through the Hims mobile app. In the weight loss category, Hims offers compounded GLP-1 medications (semaglutide and tirzepatide) as its flagship products. Injectable formulations start at approximately $199/month, with oral GLP-1 options starting lower. Hims has been one of the more prominent platforms in the compounded GLP-1 space and has launched oral semaglutide formulations as a lower-barrier alternative to injectables. Hims does not accept health insurance for its services. However, all purchases are FSA and HSA eligible, and patients can request prescriptions be sent to a local pharmacy for potential insurance coverage on the medication side. This cash-pay model means pricing is transparent and consistent, though it may not be accessible to patients who depend on insurance coverage. Hims is a public company (NYSE: HIMS) and one of the most visible consumer health brands targeting men. Its sister brand Hers serves the same product categories for women and operates on the same platform and clinical infrastructure. depression), skincare, and sexual health. Hims operates on an asynchronous telehealth model. Patients complete detailed online health intakes rather than scheduling live video appointments, and licensed clinicians review responses to determine clinical candidacy. When approved, prescriptions are written and medications ship directly from licensed pharmacy partners to the patient's home. Ongoing management — prescription renewals, dosage questions, and clinical check-ins — is handled through the Hims mobile app. In the weight loss category, Hims offers compounded GLP-1 medications (semaglutide and tirzepatide) as its flagship products. Injectable formulations start at approximately $199/month, with oral GLP-1 options starting lower. Hims has been one of the more prominent platforms in the compounded GLP-1 space and has launched oral semaglutide formulations as a lower-barrier alternative to injectables. Hims does not accept health insurance for its services. However, all purchases are FSA and HSA eligible, and patients can request prescriptions be sent to a local pharmacy for potential insurance coverage on the medication side. This cash-pay model means pricing is transparent and consistent, though it may not be accessible to patients who depend on insurance coverage. Hims is a public company (NYSE: HIMS) and one of the most visible consumer health brands targeting men. Its sister brand Hers serves the same product categories for women and operates on the same platform and clinical infrastructure.

Who it suits

Men looking for convenient, discreet access to medications for conditions that are often undertreated — including weight loss with GLP-1 medications, erectile dysfunction, hair loss, anxiety, and depression. Hims is best for patients comfortable with an app-based, asynchronous care model and willing to pay out-of-pocket. Not suitable for patients who need insurance billing, controlled substance prescriptions, or comprehensive primary care.

How Hims compares

Hims competes most directly with Ro (Roman) and Keeps in the men's health space. Compared to Ro, Hims has a broader product catalog and stronger consumer branding; Ro offers a more clinically structured weight loss program through Ro Body with integrated pharmacy. In the GLP-1 weight loss category, Hims competes with dedicated weight management platforms like Found Health and Zealthy, but distinguishes itself through lower-cost oral semaglutide formulations and a consumer-brand approach. Neither Hims nor Ro accepts insurance — this is a meaningful disadvantage compared to insurance-based weight management platforms for patients with qualifying coverage.

Care offered

• Men's Health
• GLP-1 / Weight Management

Included

• Medication Management
• Initial Evaluation & Diagnosis
• Prescription Refills

Convenience

• Async Messaging with Provider
• App-Based Care

Cost

$69–$199/mo

• Monthly subscription

Hims does not accept insurance for most services. GLP-1 injectable weight loss plans (compounded semaglutide or tirzepatide) start at $199/month; oral GLP-1 plans start at $69/month with multi-month upfront commitment. Hair loss and ED medications vary by product. All Hims purchases are FSA/HSA eligible. Prescriptions can be sent to your local pharmacy for potential insurance coverage, though this is handled outside the Hims platform.

Insurance

Self-pay accepted (insurance not confirmed)

States served by telehealth

50 states + DC

• AL
• AK
• AZ
• AR
• CA
• CO
• CT
• DE
• FL
• GA
• HI
• ID
• IL
• IN
• IA
• KS
• KY
• LA
• ME
• MD
• MA
• MI
• MN
• MS
• MO
• MT
• NE
• NV
• NH
• NJ
• NM
• NY
• NC
• ND
• OH
• OK
• OR
• PA
• RI
• SC
• SD
• TN
• TX
• UT
• VT
• VA
• WA
• WV
• WI
• WY
• DC

Telehealth providers must be licensed in the state where you are during the visit.

How to start

Visit hims.com and select the condition you want to address (weight loss, ED, hair loss, mental health, or skincare). Complete a brief online health intake, and a licensed clinician will review your responses and determine if you're a candidate. If approved, your prescription is written and medication ships directly to your door. No insurance needed.